Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications
International Journal of Molecular Sciences · 26.03.2025 · 26 (7) · 3016
DOI: 10.3390/ijms26073016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.03.2025. Verfasst von Asim J Tashkandi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Wolfson Institute of Experimental Medicine, Queens University Belfast, Belfast BT9 7BL, Northern Ireland, UK. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Mitochondria. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 321 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council, MRC.
Abstract (Originalsprache)
The growing prevalence of diabetes highlights the urgent need to study diabetic cardiovascular complications, specifically diabetic cardiomyopathy, which is a diabetes-induced myocardial dysfunction independent of hypertension or coronary artery disease. This review examines the role of mitochondrial dysfunction in promoting diabetic cardiac dysfunction and highlights metabolic mechanisms such as hyperglycaemia-induced oxidative stress. Chronic hyperglycaemia and insulin resistance can activate harmful pathways, including advanced glycation end-products (AGEs), protein kinase C (PKC) and hexosamine signalling, uncontrolled reactive oxygen species (ROS) production and mishandling of Ca2+ transient. These processes lead to cardiomyocyte apoptosis, fibrosis and contractile dysfunction. Moreover, endoplasmic reticulum (ER) stress and dysregulated RNA-binding proteins (RBPs) and extracellular vesicles (EVs) contribute to tissue damage, which drives cardiac function towards heart failure (HF). Advanced patient-derived induced pluripotent stem cell (iPSC) cardiac organoids (iPS-COs) are transformative tools for modelling diabetic cardiomyopathy and capturing human disease’s genetic, epigenetic and metabolic hallmarks. iPS-COs may facilitate the precise examination of molecular pathways and therapeutic interventions. Future research directions encourage the integration of advanced models with mechanistic techniques to promote novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellcome Wolfson Institute of Experimental Medicine, Queens University Belfast, Belfast BT9 7BL, Northern Ireland, UK.
ORCID-Profile: Asim J Tashkandi, Andrew Yacoub, Wiwit Ananda Wahyu Setyaningsih, Andriana Margariti
Förderung
- British Heart Foundation
- Medical Research Council
- MRC
Zitieren
APA
Tashkandi, A. J., Gorman, A., McGoldrick Mathers, E., Carney, G., Yacoub, A., Setyaningsih, W. A. W., Kuburas, R., & Margariti, A. (2025). Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications. International Journal of Molecular Sciences, 26(7), 3016. https://doi.org/10.3390/ijms26073016
Vancouver
Tashkandi AJ, Gorman A, McGoldrick Mathers E, Carney G, Yacoub A, Setyaningsih WAW, et al. Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications. International Journal of Molecular Sciences. 2025;26(7):3016. doi:10.3390/ijms26073016
BibTeX
@article{Tashkandi2025,
author = {Tashkandi, Asim J and Gorman, Abigail and McGoldrick Mathers, Eva and Carney, Garrett and Yacoub, Andrew and Setyaningsih, Wiwit Ananda Wahyu and Kuburas, Refik and Margariti, Andriana},
title = {Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {7},
pages = {3016},
doi = {10.3390/ijms26073016}
}
EUVIMED